In CKD, serum phosphate concentration rises and the magnitude of increased bone FGF23 production and failure of adequate coupling of FGF23 cleavage results in increased circulating levels of biologically active iFGF23 (Wolf and White, 2014). The gene discussed is FGF23; the disease is chronic kidney disease.